188 related articles for article (PubMed ID: 11328256)
21. Statin use and colorectal adenoma risk: results from the adenoma prevention with celecoxib trial.
Bertagnolli MM; Hsu M; Hawk ET; Eagle CJ; Zauber AG;
Cancer Prev Res (Phila); 2010 May; 3(5):588-96. PubMed ID: 20403998
[TBL] [Abstract][Full Text] [Related]
22. High-Intensity Versus Low-Intensity Surveillance for Patients With Colorectal Adenomas: A Cost-Effectiveness Analysis.
Meester RGS; Lansdorp-Vogelaar I; Winawer SJ; Zauber AG; Knudsen AB; Ladabaum U
Ann Intern Med; 2019 Nov; 171(9):612-622. PubMed ID: 31546257
[TBL] [Abstract][Full Text] [Related]
23. Adoption of colonoscopy surveillance intervals in subjects who received polypectomy in southern China: A cost-effectiveness analysis.
Deng Y; Ding H; Huang J; Wong MCS
J Gastroenterol Hepatol; 2023 Nov; 38(11):1963-1970. PubMed ID: 37555337
[TBL] [Abstract][Full Text] [Related]
24. Surveillance colonoscopy is cost-effective for patients with adenomas who are at high risk of colorectal cancer.
Saini SD; Schoenfeld P; Vijan S
Gastroenterology; 2010 Jun; 138(7):2292-9, 2299.e1. PubMed ID: 20226186
[TBL] [Abstract][Full Text] [Related]
25. Chemoprevention in colorectal neoplasias: what is practical and feasible?
Ricciardiello L; Roda E; Bazzoli F
Dig Dis; 2002; 20(1):70-2. PubMed ID: 12145422
[TBL] [Abstract][Full Text] [Related]
26. Cost-effectiveness of early one-year colonoscopy surveillance after polypectomy.
Hassan C; Pickhardt PJ; Di Giulio E; Kim DH; Zullo A; Morini S
Dis Colon Rectum; 2009 May; 52(5):964-71; discussion 971. PubMed ID: 19502863
[TBL] [Abstract][Full Text] [Related]
27. Virtual chromoendoscopy for the real-time assessment of colorectal polyps in vivo: a systematic review and economic evaluation.
Picot J; Rose M; Cooper K; Pickett K; Lord J; Harris P; Whyte S; Böhning D; Shepherd J
Health Technol Assess; 2017 Dec; 21(79):1-308. PubMed ID: 29271339
[TBL] [Abstract][Full Text] [Related]
28. Development and validation of a risk score for advanced colorectal adenoma recurrence after endoscopic resection.
Facciorusso A; Di Maso M; Serviddio G; Vendemiale G; Muscatiello N
World J Gastroenterol; 2016 Jul; 22(26):6049-56. PubMed ID: 27468196
[TBL] [Abstract][Full Text] [Related]
29. Risk of advanced lesions at first follow-up colonoscopy in high-risk groups as defined by the United Kingdom post-polypectomy surveillance guideline: data from a single U.S. center.
Vemulapalli KC; Rex DK
Gastrointest Endosc; 2014 Aug; 80(2):299-306. PubMed ID: 24796960
[TBL] [Abstract][Full Text] [Related]
30. Follow-up after colorectal polypectomy: a benefit-risk analysis of German surveillance recommendations.
Becker F; Nusko G; Welke J; Hahn EG; Mansmann U
Int J Colorectal Dis; 2007 Aug; 22(8):929-39. PubMed ID: 17279350
[TBL] [Abstract][Full Text] [Related]
31. Colonoscopic polypectomy--evaluation of the effectiveness and safety (single center experience).
Peterlejtner T; Szewczyk T; Buczyńska E; Zdrojewski M; Firkowski P; Kwiasowski R; Wojtowicz L
Pol Przegl Chir; 2011 Aug; 83(8):438-42. PubMed ID: 22166717
[TBL] [Abstract][Full Text] [Related]
32. Celecoxib for the Prevention of Colorectal Adenomas: Results of a Suspended Randomized Controlled Trial.
Thompson PA; Ashbeck EL; Roe DJ; Fales L; Buckmeier J; Wang F; Bhattacharyya A; Hsu CH; Chow SH; Ahnen DJ; Boland CR; Heigh RI; Fay DE; Hamilton SR; Jacobs ET; Martinez EM; Alberts DS; Lance P
J Natl Cancer Inst; 2016 Dec; 108(12):. PubMed ID: 27530656
[TBL] [Abstract][Full Text] [Related]
33. Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes: a multicentre double-blind, placebo-controlled, randomised phase 3 trial.
Higurashi T; Hosono K; Takahashi H; Komiya Y; Umezawa S; Sakai E; Uchiyama T; Taniguchi L; Hata Y; Uchiyama S; Hattori A; Nagase H; Kessoku T; Arimoto J; Matsuhashi N; Inayama Y; Yamanaka S; Taguri M; Nakajima A
Lancet Oncol; 2016 Apr; 17(4):475-483. PubMed ID: 26947328
[TBL] [Abstract][Full Text] [Related]
34. Risk of colorectal cancer following colonoscopic polypectomy.
Bertario L; Russo A; Sala P; Pizzetti P; Ballardini G; Andreola S; Spinelli P
Tumori; 1999; 85(3):157-62. PubMed ID: 10426124
[TBL] [Abstract][Full Text] [Related]
35. Tumor-associated down-regulation of 15-lipoxygenase-1 is reversed by celecoxib in colorectal cancer.
Heslin MJ; Hawkins A; Boedefeld W; Arnoletti JP; Frolov A; Soong R; Urist MM; Bland KI
Ann Surg; 2005 Jun; 241(6):941-6; discussion 946-7. PubMed ID: 15912043
[TBL] [Abstract][Full Text] [Related]
36. Chemoprevention for advanced CR neoplasia.
Moshkowitz M; Shapira S; Arber N
Best Pract Res Clin Gastroenterol; 2011 Aug; 25(4-5):623-30. PubMed ID: 22122776
[TBL] [Abstract][Full Text] [Related]
37. Role of colonoscopy and polyp characteristics in colorectal cancer after colonoscopic polyp detection: a population-based case-control study.
Brenner H; Chang-Claude J; Jansen L; Seiler CM; Hoffmeister M
Ann Intern Med; 2012 Aug; 157(4):225-32. PubMed ID: 22910933
[TBL] [Abstract][Full Text] [Related]
38. Risk of Metachronous Advanced Neoplastic Lesions in Patients with Sporadic Sessile Serrated Adenomas Undergoing Colonoscopic Surveillance.
Pereyra L; Zamora R; Gómez EJ; Fischer C; Panigadi GN; González R; Bun M; Mella JM; Omodeo M; Luna P; Amante M; Casas G; Pedreira S; Cimmino D; Boerr L
Am J Gastroenterol; 2016 Jun; 111(6):871-8. PubMed ID: 27068719
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
